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Abstract
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Following myocardial infarction (MI), activated macrophages infiltrate into the necrotic
myocardium as part of a robust pro-inflammatory response and secrete matrix metalloproteinase-9
(MMP-9). Macrophage activation, in turn, modulates the fibrotic response, in part by stimulating
fibroblast extracellular matrix (ECM) synthesis. We hypothesized that overexpression of human
MMP-9 in mouse macrophages would amplify the inflammatory and fibrotic responses to
exacerbate left ventricular dysfunction. Unexpectedly, at day 5 post-MI, ejection fraction was
improved in transgenic (TG) mice (25±2%) compared to the wild type (WT) mice (18±2%;
p<0.05). By gene expression profiling, 23 of 84 inflammatory genes were decreased in the left
ventricle infarct (LVI) region from the TG compared to WT mice (all p<0.05). Concomitantly, TG
macrophages isolated from the LVI, as well as TG peritoneal macrophages stimulated with LPS,
showed decreased inflammatory marker expression compared to WT macrophages. In agreement
with attenuated inflammation, only 7 of 84 cell adhesion and ECM genes were increased in the TG
LVI compared to WT LVI, while 43 genes were decreased (all p<0.05). These results reveal a
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novel role for macrophage-derived MMP-9 in blunting the inflammatory response and limiting
ECM synthesis to improve left ventricular function post-MI.
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1. Introduction
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After myocardial infarction (MI), circulating monocytes in the bloodstream infiltrate into the
injured myocardium and differentiate into macrophages [1]. Macrophage infiltration into the
necrotic myocardium can be detected by day 3 and peaks by day 5 post-MI [2, 3]. The
degree of macrophage activation plays a critical role in the cell-mediated inflammatory
response that follows MI. Macrophage activation post-MI is biphasic and consists of an
initial pro-inflammatory phase that overlaps with an anti-inflammatory phase [2]. Proinflammatory macrophages, also known as M1 or classically activated macrophages, have
increased production of inflammatory mediators such as interleukin-1 beta (IL-1β),
interleukin-6 (IL-6), tumor necrosis factor alpha (TNFα), and MMP-9. Pro-inflammatory
macrophages promote extracellular matrix (ECM) degradation [4]. In contrast, antiinflammatory macrophages, also referred to as M2 or alternatively activated macrophages,
have increased production of anti-inflammatory mediators such as interleukin-10 (IL-10),
transforming growth factor beta (TGFβ), and vascular endothelial growth factor (VEGF).
Anti-inflammatory macrophages stimulate ECM synthesis and scar formation [5].
Matrix metalloproteinase (MMP)-9 is a member of the MMP family of enzymes and is
classified as a gelatinase for its ability to degrade denatured collagen. MMP-9 is robustly
secreted by macrophages and degrades myocardial ECM to facilitate inflammatory cell
infiltration, among other functions [6]. In the absence of MMP-9, macrophage infiltration
into the infarct region is reduced, and remodeling of the left ventricle (LV) post-MI is
attenuated [3, 7]. Therefore, we hypothesized that overexpression of human MMP-9 in
mouse macrophages would amplify the inflammatory and fibrotic responses to exacerbate
LV dysfunction. Accordingly, we examined the effect of transgenic overexpression of
human MMP-9 in mouse macrophages after experimental MI, focusing on LV function, LV
inflammatory gene expression, macrophage infiltration and phenotype, and LV ECM gene
expression at day 5 post-MI.
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2. Materials and Methods
2.1 Mice
All animal procedures were conducted according to the “Guide for the Care and Use of
Laboratory Animals” (Eighth Edition, 2011, National Research Council) and were approved
by the Institutional Animal Care and Use Committee at the University of Texas Health
Science Center at San Antonio. The mice used in this study were male and female, 3–6
month old, WT littermates (n=16) and TG mice (n=34) overexpressing human MMP-9. Both
groups had equal distribution of sex and equal average ages. TG mice carried the human
MMP-9 cDNA (2.4 kb) transgene driven by the scavenger receptor A enhancer/promoter
(4.5 kb) as described previously [8]. MI was induced by surgical ligation of the left anterior
descending (LAD) coronary artery, as described previously [3]. The copy number for the TG
day 0 group was 3.8±1.0 copies and for the day 5 TG MI group was 3.1±0.9 copies. In the
post-MI LV macrophages, total MMP- 9 gene expression increased 15±2-fold compared to
WT levels.
J Mol Cell Cardiol. Author manuscript; available in PMC 2013 November 01.
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2.2 Echocardiography and Necropsy Evaluations
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Echocardiograms were acquired under spontaneous respiration with 0.5–2% isoflurane in a
100% oxygen mix. Electrocardiogram and heart rate were monitored throughout the imaging
procedure using a surface electrocardiogram. All images were acquired with the use of a
Vevo 770™ High-Resolution In Vivo Imaging System (Visual Sonics) and were taken at a
heart rate >400 bpm to achieve physiologically relevant measurements. Measurements were
taken from the two-dimensional parasternal long-axis and short axis (m-mode) recordings of
the LV. For each parameter, 3 images from consecutive cardiac cycles were measured and
averaged.
At 5 days post-MI, LV tissue was collected. The mice were anesthetized with 2% isoflurane,
and the coronary vasculature was flushed with cardioplegic solution [9]. The hearts were
excised and the LV and right ventricle were separated and weighed individually. The LV
was sectioned into three transverse sections and stained with 1% 2, 3, 5 triphenyltetrazolium
chloride (Sigma) for infarct area determination. The infarct (LVI) and remote (LVC) regions
were separated, individually snap frozen, and stored at −80°C for biochemical analysis. The
mid section was fixed in zinc-formalin (Fisher Scientific), paraffin-embedded, and sectioned
at 5 µm for histological examination. The lungs were also removed and weighed. For
controls, day 0 WT (n=20) and TG (n=19) mice were sacrificed as described above.
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2.3 Histological Evaluation
Immunohistochemistry was performed with the use of the Vectastain ABC Kit (Vector
Laboratories). HistoMark Black (KPL 54-75-00) was used to visualize positive staining,
with eosin as a counterstain. An antibody specific for neutrophils (anti-neutrophil, mouse
monoclonal from Cedarlane, #CL8993AP; 1:100 dilution) was used to selectively detect
neutrophils. Picrosirius red staining was used to visualize collagen content. Staining levels
were quantified using Image-Pro software (Media Cybernetics) to calculate percentage of
total area stained positive. Negative controls included no primary antibody and IgG isotype
matched controls.
2.4 LV Tissue Inflammatory and ECM Arrays
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LV tissue from WT and TG day 0 controls (3F/3M each for both groups) and WT and TG
day 5 post-MI (3F/3M each for both groups) were collected. The infarct and remote regions
from the post-MI mice were analyzed separately. RNA extraction was performed using
Trizol® Reagent (Invitrogen 15596-026), and cDNA was synthesized using RT2 First
Strand Kit (Qiagen 330401). The expression of inflammation and ECM genes was measured
using the inflammatory cytokine and receptor array and the ECM and adhesion molecule
array following the manufacturer recommendations (Qiagen PAMM-011 and PAMM-013,
respectively). Gene expression was normalized to the hypoxanthine guanine phosphoribosyl
transferase 1 (Hprt1) gene.
2.5 LV Infarct Macrophage Isolations and qRT-PCR
To isolate macrophages from 5 day LVI, we followed the preparation of single-cell
suspension from the mouse heart protocol from Miltenyi Biotech, with slight modifications.
Briefly, LVI tissue from WT (n=4) and TG (n=4) was minced and dissociated into singlecell suspension using collagenase II (600U/mL, Worthington) and DNase I (60 U/mL,
AppliChem) in Hanks’ Balanced Salt Solution (HBSS, Gibco). After 45 min incubation at
37 °C, with mechanical dissociation applied every 15 min, the cell suspension was
centrifuged, resuspended in cold HBSS and applied over pre-separation filters to remove
non-dissociated clumps (Miltenyi Biotec 130-041-407). The cells were pelleted by
centrifugation at 300 × g for 10 min and resuspended in MACS separation buffer and Red
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Blood Cell Lysis Solution (Miltenyi Biotec). The cell suspension was purified using the
mouse anti-LY-6G microbead kit (Miltenyi Biotec 130-092- 332) and applied over a
magnetic MS column (Miltenyi Biotec 130-042-201) to remove neutrophils, which were not
abundant at day 5 post-MI. The cells in the flow-through were resuspended in fresh
separation buffer, and the macrophages were sorted using the mouse/human CD11b
Microbead kit (Miltenyi Biotec 130-049-601). The CD11b positive cells were plated on
Thermanox® coverslips or in a 24-well tissue culture plate and incubated in RPMI 1640
media (Gibco) supplemented with 10% fetal bovine serum. After overnight incubation, the
adherent cells (i.e., macrophages) were washed using Hanks buffered saline solution, and
were fixed with 4% paraformaldehyde (Sigma) for 25 min and stored in phosphate buffered
saline at 4 °C for immunocytochemistry, or were collected for RNA isolation. RNA
extraction was performed by lysing the cells directly in the well using RNeasy (Qiagen
12183- 018A), and cDNA was synthesized using High Capacity RNA to cDNA Kit (ABI
4387406). Quantitative real-time PCR (qRT-PCR) was performed using taqman gene
expression assays (Applied Biosystems) for human MMP-9 (Hs00234579_m1) and mouse
MMP-9 (Mm00442991_m1). For M1 macrophage activation, IL-1β (Mm01336189_m1),
IL-6 (Mm00446190_m1), IFN-γ (Mm01168134_m1), and TNFα (Mm00443258_m1)
levels were assessed. For M2 macrophage activation, the levels of Arg1
(Mm00475988_m1), CD163 (Mm00474091_m1), mannose receptor 1 (Mm00485148_m1)
and TGFβ1 (Mm01178820_m1) were measured. Gene expression was normalized to Gapdh
(Mm99999915_g1).
2.6 Peritoneal Macrophage Isolation and qRT-PCR
Peritoneal macrophages were isolated from WT littermate (n=3F/3M) and TG (n=3F/3M)
peritoneum, and 2 × 106 cells were plated on 25 cm2 cell culture flasks in RPMI 1640 media
supplemented with 10% fetal bovine serum. After overnight incubation at 37°C, the cells
were serum starved for 24 h and treated using serum-free medium with and without LPS
(100 ng/mL, Sigma) for 24 h. The cells were washed with PBS and lysed directly in the
plate, RNA was extracted, and expression of inflammatory cytokine and receptors were
analyzed using the array described above.
2.7 Protein Extraction and Immunoblotting
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Total protein was extracted from the day 0 controls, the LVC regions, and the LVI regions
by homogenizing the sample with Sigma Reagent 4 (7 M urea, 2 M thiourea, 40 mM
Trizma® base and the detergent 1% C7BzO) and 1× Complete Protease Inhibitor Cocktail
(Roche). Protein concentrations were determined using the Bradford assay (BioRad). Due to
the high urea content in Reagent 4, protein extracts were diluted 1:40 with water for
compatibility with Bradford assay reagents. Total protein (10 μg) for each fraction of all
samples were run on 26- well, 4–12% criterion Bis-Tris gels (Bio-Rad), transferred onto
nitrocellulose membranes (Bio- Rad) and stained with MemCode™ Reversible Protein Stain
Kit (Pierce) to verify protein concentration and loading accuracy. Protein levels were
quantified by immunoblotting using the following primary antibodies: alpha smooth muscle
actin (Abcam ab5694), anti-human MMP-9 (Epitomics 1939-1), anti-mouse MMP-9
(Abcam ab38898), Mac 3 (Cedarlane CL8943AP), galectin 3 (R&D AF1197), and vimentin
(Abcam ab8545). Immunoblotting was performed as previously described [10]. Molecular
Imaging Software (Kodak) and Image J were used to measure densitometry. Densitometric
units were normalized to the densitometry of the total protein stain for the entire lane. The
groups were sub-analyzed, to determine if there were any differences based on sex, for
MMP-9, galectin-3, and Mac-3. There were no differences within the groups based on sex.
Male and female results, therefore, were combined.

J Mol Cell Cardiol. Author manuscript; available in PMC 2013 November 01.

Zamilpa et al.

Page 5

2.8 Statistical Analyses
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Data are reported as mean±SEM. Two group comparisons of untreated and treated cells
were performed using paired t-tests. One-Way ANOVA followed by the Student Newman–
Keuls post-hoc test was used for comparisons of more than two groups. A p<0.05 was
considered significant.

3. Results
3.1 5-Day post-MI Mortality
During the 5 day post-MI protocol, WT mice had a mortality rate of 0% (0 of 16 mice), and
TG mice had a mortality rate of 14.7% (5 of 34 mice; p=0.16). For the TG mortalities, 1 of
the 5 deaths (20%) was a confirmed cardiac rupture. Non-rupture related deaths, likely the
result of acute heart failure or arrhythmias, accounted for 80% of the deaths (4 of 5 mice).
3.2 Echocardiographic and Morphometric Analyses
Echocardiographic, necropsy, and infarct size analyses for WT and TG mice at 5 days postMI are shown in Table 1. The control day 0 groups demonstrated no baseline differences in
LV mass, right ventricle mass, lung mass or any of the echocardiographic parameters
measured (all p=not significant).
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In response to a similar extent of myocardial injury (average infarct size was 49% for WT
and TG; p=0.90), both WT and TG day 5 post-MI groups had significant increases in end
diastolic volume and significant decreases in posterior wall thickness when compared to
controls (all p<0.05). Additionally, end systolic volume increased in both WT and TG
animals post-MI, but the increase in end systolic volume of the TG was significantly
attenuated compared to the WT group post-MI (p<0.05 for day 5 WT vs TG).
Concomitantly, ejection fraction was also improved in the TG MI group compared to the
WT MI group (p<0.05). In further support of improved LV function in the TG group, LV
mass at necropsy did not increase post-MI in the TG mice, compared with the controls. In
contrast, the WT post-MI LV showed significant increases in mass compared with day 0
controls (p<0.05).
3.3 MMP-9 Protein Levels Post-MI
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After synthesis, most MMPs are secreted into the extracellular space as inactive enzymes
containing an N-terminus pro-domain. Enzymatic cleavage of the pro-domain results in
activation of the MMP [11]. Human pro-MMP-9 is a 92 kDa protein, and active human
MMP-9 has a relative mobility of 88 kDa, while mouse pro-MMP-9 is 105 kDa and mouse
active MMP-9 is 95 kDa. To verify expression of the transgene and activation of the human
MMP-9 in our TG animals, we used an antibody specific for human MMP-9 (Epitomics
1939-1) for immunoblotting analysis. In the LVI protein extracts of the TG group (but not
the WT), pro and active human MMP-9 were detected, indicating that expression of the
transgene was responsive to MI, and the human MMP-9 could be activated from the proform (Figure 1A). To test whether the expression of the mouse MMP-9 was affected by the
human TG, we used a mouse MMP-9 specific antibody (Abcam ab388898). Post-MI mouse
MMP-9 protein levels in the LVI were similar in both WT and TG groups (Figure 1B,
p=0.86).
3.4 Macrophage Infiltration
To test if overexpression of MMP-9 increased macrophage infiltration, we used immunoblot
analysis and antibodies for the macrophage markers galectin 3 (R&D AF1197) and Mac-3
(Cedarlane CL8943AP). Surprisingly, galectin-3 (Figure 2A, p=0.78) and Mac-3 (Figure 2B,
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p=0.39) protein concentrations were similar in the LVI of WT and TG groups post-MI,
indicating that overexpression of human MMP-9 in macrophages did not affect macrophage
infiltration at day 5 post-MI.
3.5 Collagen Levels, Myofibroblasts, and Neutrophils
To assess whether MMP-9 overexpression in macrophages had an effect on collagen
accumulation at day 5 post-MI, the LVI of WT (Figure 3A) and TG (Figure 3B) were
stained with picrosirius red. Collagen levels were similar in both groups at day 5 post-MI
(Figure 3C, p=0.11). Concomitantly, the ratio of alpha smooth muscle actin and vimentin, as
an indicator of myofibroblast levels, was also similar between the two groups (p=0.49). To
quantify neutrophil numbers, we immunostained the LVI using an antibody specific for
Ly-6G. Neutrophil numbers were similar in the LVI of WT and TG at day 5 post-MI (Figure
3D; p=0.14).
3.6 LV Inflammatory Gene Arrays
To test if MMP-9 overexpression in macrophages affects the inflammatory response postMI, we measured the inflammatory cytokine and receptor gene expression of both WT and
TG day 0 controls, WT and TG day 5 post-MI remote (LVC), and WT and TG day 5 postMI infarct (LVI) regions (Figure 4, n=6 per group, 3F/3M).
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In the day 0 controls, expression of chemokine (CXC motif) ligand 12 (Cxcl12), a strong
chemotactic molecule, was decreased in the TG MI compared to the WT MI, while
interleukin 10 receptor beta (IL10rb) and small inducible cytokine subfamily E member 1
(Scye1) were increased in the TG MI compared to the WT MI (all p<0.05). None of the
other 81 genes evaluated were different between the groups at day 0.
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Because macrophages concentrate in the infarct region, the majority of the inflammatory
gene expression post-MI changes were, as expected, detected in the infarct region. Out of 84
genes examined, 21 genes were significantly differentially expressed in the WT LVI
compared to WT control (Supplemental Table 1 and Figure 4; all p<0.05). In addition, 23
inflammatory genes were decreased in the TG LVI compared to the WT LVI (Figure 4; all
p<0.05). In the remote region (LVC), only the expression of Scye1 decreased in the TG
mice compared to WT mice (Figure 4; p<0.05). Interestingly, SPP1 and SCYE1 expression
levels were significantly elevated in WT LVI compared to WT day 0 control, indicating
strong macrophage activation in WT LV post-MI. Levels were significantly attenuated in the
TG LVI compared to WT LVI. Pf4 is a strong chemoattractant for neutrophils and
fibroblasts. In the inflammatory gene array panel, Pf4 gene expression levels were highly
elevated in both WT LVC and LVI, and this elevation was significantly attenuated in TG
LVC and LVI, suggesting blunted fibroblast activities, which may reduce scar formation. In
addition, Cxcl12 was the most down-regulated gene in TG LVI, and Cxcl12 has been shown
to play important roles in macrophage migration.
3.7 LV Infarct Macrophage and Peritoneal Macrophage Gene Expression
To further investigate the regulatory effects of MMP-9 overexpression post-MI, we isolated
macrophages from WT (n=4) and TG (n=4) LVI tissue and measured gene expression levels
of M1 and M2 activation markers. Representative images for WT (Figure 5A) and TG
macrophages (Figure 5B) stained with anti-F4/80 (green) and Dapi (blue) qualitatively
showed distinct phenotypes, in that the WT cells showed more robust staining for the F4/80
macrophage marker. To verify transgene activity in the isolated macrophages, we quantified
the expression of the human MMP-9 transgene (Figure 5C). As expected, human MMP-9
was observed in TG macrophages but not WT macrophages. Interestingly, expression of the
M1 activation markers IL-1β (Figure 5D) and TNFα (Figure 5E) were decreased (p<0.05) in
J Mol Cell Cardiol. Author manuscript; available in PMC 2013 November 01.
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the TG macrophages isolated from the LVI, indicating that MMP-9 overexpression served to
dampen the proinflammatory response. Interestingly, the expression of other M1 activation
markers (IL-6 and IFN-γ) and M2 activation markers (arginase 1, CD163, mannose receptor
1 and TGFβ1) were similar in both WT and TG macrophages isolated from the LVI at day 5
post-MI (all p=not significant). These results suggest that MMP-9 overexpression has
specific regulatory effects on IL-1β and TNFα.
As a complement experiment, we used the inflammatory gene and receptor array to measure
gene expression of peritoneal macrophages from WT (n=6) and TG mice (n=6) treated with
LPS for 24 h (Supplemental Table 2). Of the 84 genes evaluated, 27 showed significant
differences (Figure 6). Similar to the response observed in the LVI tissue and isolated LVI
macrophages, reduced inflammatory gene expression (including IL-1β and TNFα ) was
detected in the isolated TG peritoneal macrophages treated with LPS, compared to the WT
macrophages treated with LPS.
3.8 LV Extracellular Matrix Gene Arrays
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To measure the effects of a reduced inflammatory response on the ECM response post-MI,
we measured the expression of 84 ECM and adhesion molecules of matched WT and TG
day 0 controls, WT and TG day 5 post-MI remote (LVC), and WT and TG day 5 post-MI
infarct (LVI) regions (Supplemental Table 3 and Figure 7). In the day 0 controls, laminin
beta 2 and MMP-15 were the only two genes altered in the TG LV and both were decreased
in the TG compared to the WT controls (p<0.05).
Post-MI, gene expression levels of Cd44, ctnna1, itgb2, lama2, MMP-2, Sgce, and Vcam1
were all decreased in the TG LVC, compared to the WT LVC (all p<0.05). In line with a
decreased inflammation in the infarct region, 43 of 84 ECM and adhesion genes decreased
in the TG LVI compared to the WT LVI (all p<0.05). Interestingly, Adamts2, ECM1,
fibronectin, TIMP-2, MMP-14, periostin, and tenascin were increased in the TG LVI
compared to the WT LVI (all p<0.05), suggesting that these proteins may play an important
role in the reparative process. Additionally, these results indicate that decreased
inflammation dampened the fibrotic response post-MI.

4. Discussion
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MMP-9 is a critical enzyme affiliated with post-MI remodeling [12]. In this study, we
examined the effect of overexpression of human MMP-9 in mouse macrophages, with
respect to left ventricular function, inflammatory gene and receptor expression, macrophage
infiltration and activation, and ECM and adhesion molecule expression. The significant
findings of this study were that MMP-9 overexpression in macrophages resulted in 1)
improved left ventricular function, 2) reduced inflammatory responses in the LV infarct
tissue and in isolated macrophages, and 3) decreased fibrotic responses at day 5 post-MI.
These results suggest that MMP-9 regulates the inflammatory response to MI, which
indirectly influences the fibrotic response.
Optimal infarct healing relies on the timely resolution of the inflammatory response. At the
same time, macrophage depletion during the first week after MI results in defective
myocardial healing [13, 14]. Interestingly, the degree of macrophage activation and the
heterogeneity of macrophage subsets regulate chemotaxis, phagocytosis of necrotic
myocytes and apoptotic neutrophils, angiogenesis, ECM turnover, and fibroblast activation
[4, 15].
MMP-9 is elevated early in the plasma and myocardium of post-MI patients and multiple
animal models, and targeted deletion of MMP-9 in mice has been shown to protect against
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cardiac rupture and adverse ventricular remodeling post-MI [7, 16–18]. Because of the
beneficial effects observed in the MMP-9 null mice post-MI, we predicted that transgenic
overexpression of human MMP-9 in mouse macrophages would result in adverse
remodeling and an increased incidence of rupture. At 5 day post-MI, however, survival was
not affected by overexpression of MMP-9 in macrophages. Further, LV function was also
improved.
Based on previous results with the MMP-9 null mice showing impaired macrophage
infiltration at day 5 post-MI, we hypothesized that increased MMP-9 would stimulate
macrophage infiltration and ECM degradation [3, 6]. Our results indicate that MMP-9
overexpression in macrophages did not affect macrophage infiltration. As neutrophils are
another source of MMP-9, our results suggest that neutrophil-derived MMP-9 may play a
more important role in macrophage migration than macrophage-derived MMP-9. Our results
agree with previous literature using these mice in a model of asthma, where macrophage
numbers that infiltrated into the lung were similar between WT and TG [19].
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Our findings indicate that MMP-9 overexpression in macrophages reduces the expression of
inflammatory genes and receptors in the LV infarct region post-MI. Moreover, MMP-9
overexpression regulated the inflammatory response of isolated macrophages from the LV
infarct and LPS-stimulated peritoneal macrophages. It is important to mention that mRNA
levels in isolated macrophages were evaluated after plating the cells, which could modify
expression levels. As a consequence of reduced inflammation, the gene expression level of
ECM and adhesion molecules was decreased in the TG mice post-MI. Of note, macrophage
MMP-9 overexpression significantly decreased expression of mouse MMPs -2, -3, -7, -8, -9,
-10, -12, and -13, indicating that MMP-9 may be an important upstream mediator of these
other MMPs. Interestingly, Adamts2, ECM1, fibronectin, MMP-14, periostin, tenascin, and
TIMP-2 were upregulated in the TG compared to WT post-MI, indicating a beneficial role in
cardiac wound healing at day 5 post-MI by stimulating a more robust scar formation. The
fact that MMP-14 increased with MMP-9 overexpression suggests that MMP-14 may be
upstream of MMP-9 or that MMP-14 may share a common pathway with MMP-9.
Fibronectin expression during cardiac repair has been shown to serve as a scaffold for
reparative ECM deposition and pluripotent cell migration [20–23]. In the post-MI setting,
periostin null mice have been shown to have increased rupture rates as a result of decreased
myocardial stiffness and collagen accumulation [24, 25]. Interestingly, tenascin C null
animals have a phenotype similar to the seen in the TG mice; namely, attenuated LV
remodeling post-MI [26]. Moreover, TIMP-2 null mice have severe inflammation and
greater infarct expansion that exacerbated ventricular dilation [27]. These seven genes
provide a targeted list for further studies into MMP-9 dependent mechanisms of LV
remodeling.
Traditionally, MMP-9 is considered an enzyme that can degrade ECM; however, our
findings indicate MMP-9 has a central role in the regulation of a multitude of cytokines and
chemokines, including the pro-inflammatory genes IL-1β and TNFα. Consistent with our
results, Cabrera and colleagues reported reduced pulmonary fibrosis in the bleomycin
treated TG MMP- 9 mice that was due to increased MMP-9 activity and cleavage of the
MMP-9 substrate insulinlike growth factor binding protein-3 [8]. Interestingly, in our
inflammatory array, the gene expression of small inducible cytokine subfamily E, member 1
(SCYE1), a known MMP-9 substrate, was elevated at baseline and its expression decreased
in both the LV remote and infarct regions of TG compared to the WT post-MI [28]. SCYE1,
also known as EMAPII, is a proinflammatory cytokine whose expression is induced by
apoptosis [29–31]. Although the mechanisms by which SCYE1 regulates inflammation are
not well understood, our findings suggest that overexpression of MMP-9 may regulate the
inflammatory response in part through SCYE1.
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In comparison to the MMP-9 null mice, which demonstrate reduced macrophage infiltration
and collagen accumulation to improve LV function post-MI, our findings indicate that
macrophage-overexpression of MMP-9 have a similar functional end product of reduced
inflammation and fibrosis, albeit through different mechanisms.
In conclusion, this study demonstrated that human MMP-9 overexpression in mouse
macrophages imparts a positive consequence on LV remodeling at day 5 post-MI. The
MMP-9 transgenic mice showed improved left ventricular function and reduced
inflammatory response with a concomitant decrease in ECM protein expression. Our data
suggest that MMP-9 overexpression imparts a beneficial consequence in the setting of acute
inflammation and post-MI remodeling.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Human MMP-9 levels increased in the TG LVI. (A) Human pro (92 kDa) and active
MMP-9 (88 kDa) increased in the LVI of TG mice at day 5 post-MI. + is the human
macrophage extract positive control for human MMP-9 (B) Mouse MMP-9 (105 kDa) levels
were not changed in response to activity of the human transgene. + is mouse spleen extract
used as a positive control for mouse MMP-9. Sample sizes are n=10 for WT LVI and n=13
for TG LVI; * p<0.05 for human MMP-9; and p=0.86 for mouse MMP-9.
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Figure 2.

Macrophage numbers were similar in WT and TG mice at day 5 post-MI. (A) Galectin- 3
(B) Mac-3 protein levels were similar in the LV infarct at day 5 post-MI. LVI-infarct region;
+ is spleen extract positive control. Sample sizes are n=10 for WT LVI and n=13 for TG
LVI; p=0.78 for Galectin-3 and p=0.39 for Mac-3.
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Figure 3.
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Collagen levels and neutrophils were similar in WT and TG mice at day 5 post-MI. Midventricular, transverse sections of the WT LVI (A) and TG LVI (B) stained with picrosirius
red indicated no difference in collagen content at day 5 post-MI (C, p=0.11).
Immunostaining using an anti-neutrophil antibody indicated similar number of neutrophils
in both groups at day 5 post-MI (D, p=0.14).
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Figure 4.
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Expression of inflammatory cytokine and receptor genes were decreased in the left ventricle
infarct (LVI) post-MI of TG compared to WT mice. The expression of 84 cytokine and
receptor genes were quantified in the wild type (WT) and transgenic (TG) day 0 controls and
in the WT remote region (WT LVC), WT infarct region (WT LVI), TG remote (TG LVC),
and TG infarct (TG LVI) at day 5 post-MI. By ANOVA, p<0.05 for 1-WT vs WT LVC or
TG vs TG LVC; 2-WT vs WT LVI or TG vs TG LVI; 3-WT vs TG; 4-WT LVC vs TG
LVC; and 5-WT LVI vs TG LVI.
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Figure 5.

Macrophages isolated from the infarct region of TG mice at day 5 post-MI have reduced
expression of pro-inflammatory markers IL-1β and TNFα compared to WT post-MI LV.
(A) WT macrophages and (B) TG macrophages isolated from the LVI stained with F4/80
(green) and Dapi (blue). Scale bar is 20 µm. (C) Human MMP-9 (hMMP-9) was expressed
in macrophage isolated from the LV infarct at day 5 post-MI in TG but not WT mice. (D)
IL-1β and (E) TNFα levels were significantly decreased in TG macrophages compared to
WT macrophages. Sample sizes are n=4 for both groups, * p<0.05 vs WT LVI macrophages.
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Figure 6.
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TG peritoneal macrophages have decreased gene expression of inflammatory cytokine and
receptors after treatment with LPS. We quantified the expression of 84 inflammatory
cytokine and receptor genes of untreated WT and TG peritoneal macrophages and LPStreated WT (WT+LPS) and transgenic peritoneal macrophages (TG+LPS). By paired t-test,
p<0.05 for a-WT vs WT+LPS or TG vs TG+LPS; and by ANOVA, p<0.05 for 1-WT vs WT
+LPS or TG vs TG+LPS and 2-WT+LPS vs TG+LPS.
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Figure 7.

Expression of ECM and adhesion molecule genes are decreased in the TG mice left ventricle
infarct (LVI) at day 5 post-MI compared to WT LVI. The expression of 84 ECM molecule
and adhesion genes were quantified in the wild type (WT) and transgenic (TG) day 0
controls and in the WT remote region (WT LVC), WT infarct region (WT LVI), TG remote
region (TG LVC) and TG infarct region (TG LVI). By ANOVA, p<0.05 for 1-WT vs WT
LVC or TG vs TG LVC; 2-WT vs WT LVI or TG vs TG LVI; 3-WT vs TG; 4-WT LVC vs
TG LVC; and 5-WT LVI vs TG LVI.
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WT
control
(n=20)

MMP-9 TG
control
(n=19)

WT
5 day MI
(n=16)

MMP-9 TG
5 day MI
(n=29)

Body Weight (g)

27.2±1.4

28.0±1.4

23.7±1.1*

22.6±0.8*

Heart Rate (bpm)

447±6

455±8

485±11

487±10

0.96±0.02

0.97±0.02

0.62±0.02*

0.61±0.03*

End Diastolic Volume (µl)

45±2

46±3

83±4*

74±4*

End Systolic Volume (µl)

17±1

18±1

69±4*

56±4*†

Ejection Fraction (%)

61±2

61±2

18±2*

25±2*†

LV mass (mg)

81±3

85±5

99±4*

93±3

LV Free Wall Thickness (systolic, mm)

RV mass (mg)

19±1

19±1

20±1

18±1

Lung wet weight (mg)

149±5

126±4

175±15

146±10

LV mass/ BW ratio (mg/g)

3.0±0.1

3.1±0.1

4.2±0.1*

4.1±0.1*

49±2

49±2

Infarct Size (%)
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Control is day 0 samples. LV- left ventricle; RV- right ventricle;

*

p<0.05 vs control and

†

p<0.05 vs WT MI by ANOVA.
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